SHIMADZU Scientific Instruments has announced the release of its AXIMA Resonance MALDI QIT TOF mass spectrometer which has been designed as an integrated approach to life science and drug development.
Shimadzu says the AXIMA Resonance combines the simplicity of MALDI, the power of MSn, and the accuracy and resolution of TOF to provide researchers a unique solution to the next generation of structural and sequencing challenges.
Additionally, Shimadzu claims the AXIMA Resonance is able to produce high-quality results with high mass resolution and mass accuracy across MS and MSn analyses, variable energy CID control on the fly, high-resolution precursor ion selection up to 1000 FWHM, and highly efficient trapping functionality.
The AXIMA Resonance is compatible with software suits from fully automated data-dependent peptide mass fingerprinting to tissue imaging to post translational modification investigation, accelerate research.